The revision of the ERP system reduced the complexity of existing procedures. After the implementation of changes, less variability in outcomes was observed, and as a result, Saudi Food and Drug Authority received fewer appeals. The Saudi Arabian experience offers valuable insights for other countries planning to implement or refine ERP procedures. It serves as input for evaluating ERP as a pricing policy and for assessing the impact of policy design on various factors, such as prices and access to medicines.
Hussain et al. (Sun,) studied this question.